Stereotactic ablative radiotherapy for prostate cancer treatment has been proven effective at five doses versus 20 with ...

In a new study led by the UCLA Health Jonsson Comprehensive Cancer Center, investigators show that using advanced MRI imaging and targeted focal therapy can help many men with low- to ...

Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and clinical trial results at the 2025 American Society for Radiation Oncology (ASTRO) ...

Thousands of men in England with prostate cancer are to be offered high powered “precision” radiotherapy that will cut their ...

Thousands of men with early-stage prostate cancer in England will soon have access to a new form of radiotherapy on the NHS ...

A new clinical trial finds that people with a limited number of metastases from recurrent prostate cancer lived significantly longer without disease progression when they received a ...

There are around 46,000 new cases of prostate cancer each year in England and Wales, with 13% of these cases showing signs of ...

The UCLA trial is currently enrolling patients. Clinical trial compares two targeted radiation therapies for recurrent prostate cancer. New AI tool, ProCUSNet, detects prostate cancer more accurately ...

New NHS radiotherapy set to ‘transform’ treatment for thousands of men with prostate cancer - Prostate cancer is the most ...

Here is how robotic surgeries are paving way for new gen cancer treatment in the country - Read on to know all about it.

Targeted therapies are medicines to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted therapies work ...

In a new study led by the UCLA Health Jonsson Comprehensive Cancer Center, investigators show that using advanced MRI imaging and targeted focal therapy can help many men with low- to ...